Mesoblast (MESO) EBIT Margin (2014 - 2023)
Mesoblast (MESO) recorded EBIT Margin of 214.92% in the year ended Jun 30, 2026, down 286.21 percentage points from 501.13% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) EBIT Margin (2014 - 2023) Analysis & Trends
Starting with the year ended Jun 30, 2015, Mesoblast's EBIT Margin history includes 12 years.
- Annual EBIT Margin has a five-year change of +1699.23 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 is the lowest annual EBIT Margin since the year ended Jun 30, 2022.
- Per Business Quant data, MESO's EBIT Margin was 501.13% in the year ended Jun 30, 2025 (-695.04 pp), 1196.17% in the year ended Jun 30, 2024 (+25.70 pp), 1170.47% in the year ended Jun 30, 2023 (+2236.71 pp) and -1066.24% in the year ended Jun 30, 2022 (+418.07 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Mesoblast | 1.66 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -818.47% |
| Mar 31, 2023 | -704.59% |
| Dec 31, 2022 | -860.78% |
| Sep 30, 2022 | -824.22% |
| Jun 30, 2022 | -772.03% |
| Mar 31, 2022 | -867.03% |
| Dec 31, 2021 | -866.34% |
| Sep 30, 2021 | -516.61% |
| Jun 30, 2021 | -1,180.03% |
| Mar 31, 2021 | -1,157.46% |
| Dec 31, 2020 | -964.93% |
| Sep 30, 2020 | -1,635.86% |
| Jun 30, 2020 | -4,573.89% |
| Mar 31, 2020 | -110.52% |
| Dec 31, 2019 | -1,053.99% |
| Sep 30, 2019 | -22.52% |
| Jun 30, 2019 | -1,022.11% |
| Mar 31, 2019 | -1,924.02% |
| Dec 31, 2018 | -1,335.99% |
| Sep 30, 2018 | -150.86% |
API Access
Mesoblast EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();